We recently reported that the overexpression of the NFκB (p65) super-repressor inhibited GD3S expression in breast cancer cells [6], suggesting that NFκB signaling could be an important regulator in BCSC tumorigenic functions. The gene discussed is NFKB1; the disease is breast carcinoma.